Risperidone (4 mg tablets): Supply issue

Supply issue Active

There is a supply issue affecting Risperidone (Teva) tablets 4 mg presentation.

13 August 2025 | Update

Additional stock of the Risperdal 4 mg is available. Where the 4 mg tablet isn't available, two x 2 mg risperidone tablets can be taken.

We will update this page once the Teva stock is available.

Affected product

There is a supply issue affecting:

Chemical Brand Presentation Pharmacode Subsidy Measure/Qty
Risperidone Risperidone (Teva) Tab 4 mg 2466937 $6.25 per 60

Schedule listing: Risperidone(external link)

Alternative: two x 2 mg tablets

Stock of the 4 mg Risperdal alternative is arriving by late July (it may take up to 2 weeks to reach pharmacies around the motu).

We are advised that two x 2 mg risperidone tablets can be used as an alternative where a 4 mg is not available.

Chemical Brand Presentation Pharmacode Subsidy Measure/Qty
Risperidone Risperdal Tab 4 mg 245402 $6.25 per 60

Medsafe datasheet for Risperdal(external link)

The oral liquid is also available in significant quantities. However, people would need a new prescription.

We listed other brands and strengths to support earlier supply issues affecting risperidone.

Resupply details

We will confirm release of the Teva stock by the end of September 2025. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)